ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VPHM Viropharma Incorporated (MM)

49.98
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Viropharma Incorporated (MM) NASDAQ:VPHM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 49.98 0 01:00:00

VIROPHARMA INCORPORATED INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of ViroPharma Inc. (VPHM) Over the P...

11/11/2013 11:30pm

Business Wire


Viropharma Incorporated (MM) (NASDAQ:VPHM)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Viropharma Incorporated (MM) Charts.

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of ViroPharma Inc.

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of ViroPharma Inc. (“ViroPharma” or the “Company”) (NasdaqGS:VPHM) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Shire (NasdaqGS:SHPG) in a cash deal valued at approximately $4.2 billion. Under the terms of the proposed transaction, ViroPharma’s stockholders will receive $50.00 for each share of ViroPharma common stock they own.

Request more information now by clicking here: www.faruqilaw.com/VPHM. There is no cost or obligation to you.

The investigation focuses on whether ViroPharma’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether and by how much this proposed transaction undervalues the Company to the detriment of ViroPharma’s shareholders.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

If you own common stock in ViroPharma and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/VPHM or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

Faruqi & Faruqi, LLP369 Lexington Avenue, 10th FloorNew York, NY 10017Attn: Juan E. Monteverde, Esq.jmonteverde@faruqilaw.comToll Free: 877-247-4292Phone: 212-983-9330

1 Year Viropharma Incorporated (MM) Chart

1 Year Viropharma Incorporated (MM) Chart

1 Month Viropharma Incorporated (MM) Chart

1 Month Viropharma Incorporated (MM) Chart